Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration.

Suppr

超能文献

作者信息

Liuzzi A, Chiodini P G, Botalla L, Cremascoli G, Müller E E, Silvestrini F

出版信息

J Clin Endocrinol Metab. 1974 May;38(5):910-2. doi: 10.1210/jcem-38-5-910.

DOI:10.1210/jcem-38-5-910

PMID:4823928

Abstract

摘要

相似文献

Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration.

J Clin Endocrinol Metab. 1974 May;38(5):910-2. doi: 10.1210/jcem-38-5-910.

Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-alpha-ergocryptine.正常人和肢端肥大症患者在给予2-溴-α-麦角隐亭后血浆生长激素水平的变化

J Clin Endocrinol Metab. 1975 Mar;40(3):363-6. doi: 10.1210/jcem-40-3-363.

Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patients.

J Clin Endocrinol Metab. 1975 Apr;40(4):705-8. doi: 10.1210/jcem-40-4-705.

Unaltered plasma GH levels in acromegalics and normal men and women after administration of (Pyro)Glu-Ser-Gly-NH2, a proposed GH-releasing hormone.

J Clin Endocrinol Metab. 1974 Jun;38(6):1134-6. doi: 10.1210/jcem-38-6-1134.

J Clin Endocrinol Metab. 1977 Jan;44(1):78-84. doi: 10.1210/jcem-44-1-78.

Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.

J Clin Endocrinol Metab. 1974 Nov;39(5):871-6. doi: 10.1210/jcem-39-5-871.

Effects of sumatriptan on growth hormone releasing hormone-stimulated growth hormone secretion in acromegaly.

Recenti Prog Med. 1997 Jun;88(6):264-8.

Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.肢端肥大症患者和正常男性的脉冲式生长激素分泌：生长激素释放激素输注的影响

J Clin Endocrinol Metab. 1990 Sep;71(3):585-90. doi: 10.1210/jcem-71-3-585.

Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154).肢端肥大症患者中阿片系统对生长激素分泌的异常调控：一项使用纳洛酮和2-溴-α-麦角隐亭（CB 154）的研究

Med Biol. 1981 Feb;59(1):58-63.

[125I]hGH metabolism in acromegaly: effects of chronic treatment with 2-Br-alpha-ergocryptine.

J Clin Endocrinol Metab. 1978 Jul;47(1):110-8. doi: 10.1210/jcem-47-1-110.

引用本文的文献

Pegvisomant and cabergoline combination therapy in acromegaly.培维索孟和卡麦角林联合治疗肢端肥大症。

Pituitary. 2013 Mar;16(1):101-8. doi: 10.1007/s11102-012-0382-z.

Pharmacological therapy for acromegaly: a critical review.肢端肥大症的药物治疗：一项批判性综述。

Drugs. 2004;64(16):1817-38. doi: 10.2165/00003495-200464160-00007.

Somatostatin analogs in medical treatment of acromegaly.生长抑素类似物在肢端肥大症医学治疗中的应用

Endocrine. 2003 Apr;20(3):271-8. doi: 10.1385/ENDO:20:3:271.

Medical management of growth hormone-secreting pituitary adenomas.生长激素分泌型垂体腺瘤的医学管理

Pituitary. 2002;5(2):67-76. doi: 10.1023/a:1022356313153.

Acromegaly: historical perspectives and current therapy.肢端肥大症：历史回顾与当前治疗方法

J Neurooncol. 2001 Sep;54(2):129-37. doi: 10.1023/a:1012949214960.

Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients.卡麦角林在高催乳素血症和肢端肥大症患者长期治疗中的应用。

J Endocrinol Invest. 1997 Oct;20(9):537-46. doi: 10.1007/BF03348016.

Bromocriptine treatment over 12 years in acromegaly: effect on glucose tolerance and insulin secretion.

Clin Investig. 1993 May;71(5):372-8. doi: 10.1007/BF00186626.

Long-term treatment of acromegalic patients with repeatable parenteral depot-bromocriptine.使用可重复注射的长效溴隐亭对肢端肥大症患者进行长期治疗。

Clin Investig. 1993 Jul;71(7):547-51. doi: 10.1007/BF00208479.

Acromegaly. Recognition and treatment.肢端肥大症。识别与治疗。

Drugs. 1994 Mar;47(3):425-45. doi: 10.2165/00003495-199447030-00004.

Bromocriptine therapy in acromegaly. A long-term review of 35 cases.溴隐亭治疗肢端肥大症。35例长期回顾。

Postgrad Med J. 1981 Apr;57(666):210-6. doi: 10.1136/pgmj.57.666.210.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验